Magnetoencephalography by Optical Pumping Magnetometer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1+
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

MagnetoEncephaloGraphy (MEG) is a method of recording brain activity with high temporal resolution and good spatial resolution, compared to current recording techniques such as ElectroEncephaloGraphy (EEG). The main limitation of MEG is its cost due to the sensors used, the Super Quantum Interference Devices (SQUID). These require a complex infrastructure from an instrumentation point of view to operate, requiring liquid helium, most often at a loss, at increasing cost. Optical Pumping Magnetometers (OPM) type sensors represent a promising alternative to SQUIDs sensors, especially since they do not require helium cooling.

The purpose of this project is to Identify biomarkers in Magnetoencephalography of normal brain development in healthy adults, premature and term newborns from "a priori" obtained by the classical technique of High Resolution EEG performed.

Eligibility criteria

Qualifiers

For healthy adult volunteers

Age between 18 and 65

No pathology, no treatment

No toxicant intake

Disqualifiers

Subject and Patients "not compatible" MEG. Wearers of prosthesis or pacemaker likely to generate artefacts interfering with the measurement. There is no danger to the subject, but the measurement itself may be impossible.

Patients who cannot stand to stand still for a few minutes.

Newborn on ventilatory assistance or infusion

Newborn baby not meeting the age criteria

Trial design

Treatments tested in this trial

  • Magnetoencephalography

Treatment groups

70 Participants
are divided into 4 treatment groups